We have previously shown that a nonlethal dose of lipopolysaccharide (LPS) decreases L-selectin expression of neutrophils (PMNs), thereby preventing PMN-mediated reperfusion injury in the isolated heart. In the present study we determined whether or not that dose of LPS would protect hearts during in vivo ischemia and reperfusion by preventing PMN-induced reperfusion injury. Rats receiving saline vehicle showed marked myocardial injury (necrotic area/area at risk = 82% ± 2%) and significant depression in left ventricular function as assessed in the isolated isovolumic heart preparation at constant flow rates of 5, 10, 15, and 20 ml/min. The administration of LPS (100 μg/kg body wt) 7 hr prior to ischemia resulted in a reduction in myocardial damage (necrotic area/area at risk = 42% ± 3%) and preservation of function. Myocardial function was similar to that of sham ischemic saline- and LPS-treated rats. Moreover, PMN infiltration as determined by histology was quantitatively more severe in hearts of saline-treated rats than in hearts of LPS-treated rats. Isolated hearts from vehicle- and LPS-treated animals undergoing sham ischemia in vivo recovered to the same extent after in vitro ischemia/reperfusion, suggesting that LPS did not induce protection by altering intrinsic properties of the heart. Our results indicate that LPS-induced protection of the heart from in vivo PMN-mediated ischemia/reperfusion injury may be due to decreased L-selectin expression of PMNs in LPS-treated animals.
BeckmanJS, BeckmanT, ChenJ, MarshallPA, FreemanBA. Apparent hydroxyl radical production by peroxynitrite: Implications for endothelial injury from nitric oxide and superoxide. Proc Natl Acad Sci U S A87:1620–1624, 1990.
2.
IgnarroLG. Biological actions and properties of endothelium-derived nitric oxide formed and released from artery and vein. Circ Res65(1):1–21, 1989.
3.
MuradF.Cyclic guanosine monophosphate as a mediator of vasodilation. J Clin Invest78:1–5, 1986.
4.
ZweierJL, FlahertyJT, WeisfeldtML. Observation of free radical generation in the post-ischemic heart. Proc Natl Acad Sci U S A84:1404–1407, 1987.
5.
RossenRD, SwainJL, MichaelLH, WeakleyS, GianniniE, EntmanML. Selective accumulation of the first component of complement and leukocytes in ischemic canine heart muscle: A possible indicator of an extra-myocardial mechanism of ischemic injury. Circ Res57:119–130, 1985.
6.
RossenRD, MichaelLH, KagiyamaA, SavageHE, HansonG, RiesbergMA, MoakeJN, KimSH, SelfD, WeakleyS, GianniniE, EntmanML. Mechanism of complement activation after coronary artery occlusion: Evidence that myocardial ischemia in dogs causes release of constituents of myocardial subcellular origin that complex with human C1q in vivo.Circ Res62:572–584, 1988.
7.
SchaferH, MatheyC, HugoF, BhakdiS.Deposition of the terminal C5b-9 complex in infarct areas of human myocardium. J Immunol137:1945–1949, 1986.
8.
LeferAM, LeferDL. Endothelial dysfunction in myocardial ischemia and reperfusion: Role of oxygen-derived free radicals. Bas Res Cardiol86(Suppl 2):109–116, 1991.
9.
SimpsonPJ, ToddRFIII, MickelsonJK, FantoneJC, GallagherKP, LeeKA, TamuraY, CroninM, LucchesiBR. Sustained limitation of myocardial reperfusion injury by a monoclonal antibody that alters leukocyte function. Circulation81:226–237, 1990.
10.
BrownJM, GrossoMA, TeradaLS, WhitmanGJR. Endotoxin pretreatment increases endogenous myocardial catalase activity and decreases ischemia-reperfusion injury of isolated rat hearts. Proc Natl Acad Sci U S A86:2516–2520, 1989.
11.
EisingGP, MaoL, Schmid-ShonbeinGW, EnglerRL, RossJ.Effects of induced tolerance to bacterial lipopolysaccharide on myocardial infarct size in rats. Cardiovasc Res31:73–81, 1996.
12.
McDonoughKH, CauseyKM. Sepsis protects the heart of alcoholic rats from ischemia-reperfusion injury. Alcohol Clin Exp Res18(6):1423–1429, 1994.
13.
YaoZ, AuchampachJA, PieperGM, GrossGJ. Cardioprotective effects of monophosphoryl lipid A, a novel endotoxin analogue in dogs. Cardiovasc Res27:832–838, 1993.
14.
YaoZ, RasmussenJL, HirtJL, MeiDA, PieperGM, GrossGL. Effects of monophosphoryl lipid A on myocardial ischemia/reperfusion injury in dogs. J Cardiovasc Pharmacol22:653–663, 1993.
15.
McDonoughKH, GiaimoME, MillerHI. Effects of endotoxin on the guinea pig heart response to ischemia reperfusion injury. Shock4(2):139–142, 1995.
16.
NelsonDW, BrownJM, BanerjeeA, BensardDD, RogersKB, Locke-WinterCR, AndersonBO, HarkenAH. Pretreatment with a nontoxic derivative of endotoxin induces functional protection against cardiac ischemia/reperfusion injury. Surgery110:356–369, 1991.
McDonoughKH, CauseyKM. Effects of sepsis on recovery of the heart from 50 min ischemia. Shock1(6):432–437, 1994.
19.
DonnellyTJ, SieversRE, VissernFU, WelchWJ, WolfeCL. Heat shock protein induction in rat hearts: A role for improved myocardial salvage after ischemia and reperfusion?Circulation85:769–778, 1992.
20.
McCallT, WhittleBJR, Boughton-Smith, MoncadaS.Inhibition of FMLP-induced aggregation of rabbit neutrophils by nitric oxide. Br J Pharmacol95:517, 1988.
21.
KleinNJ, LevinM, StrobelS, FinnA.Degradation of glycosaminoglycans and fibronectin on endotoxin-stimulated endothelium by adherent neutrophils: Relationship to CD1 lb/CD18 and L-selectin expression. J Infect Dis167:890–898, 1993.
22.
LynamEB, SimonSI, RochonYP, SklarLA. Lipopolysaccharide enhances CD11b/CD18 function but inhibits neutrophil aggregation. Blood83(11):3303–3311, 1994.
23.
RochonYP, SimonSI, LynamEB, SklarLA. A role for lectin interactions during human neutrophil aggregation. J Immunol152:1385–1395, 1994.
LiptonBP, BautistaAP, DelcarpioJB, McDonoughKH. Effects of endotoxin on neutrophil-mediated ischemia/reperfusion injury in the isolated perfused rat heart. Am J Physiol280:H802–H811, 2001.
26.
PettyMA, DowJ, GrisarJM, De JongM.Effect of a cardioselective α-tocopherol analogue on reperfusion injury in rats induced by myocardial ischaemia. Eur J Pharmacol192:383–388, 1991.
27.
HumphreySM, ThomsonRW, GavinJB. The effect of an isovolumic left ventricle on the coronary vascular competence during reflow after global ischemia in the rat heart. Circ Res49(3):784–791, 1981.
28.
MurrayCE, JenningsRB, ReimerKA. Preconditioning with ischemia: A delay of lethal cell injury in ischemic myocardium. Circulation74:1124–1136, 1986.
29.
ArmstrongS, GanoteCE. Adenosine receptor specificity in preconditioning of isolated cardiomyocytes: Evidence of A3 receptor involvement. Cardovasc Res28:1049–1056, 1994.
30.
LiuGS, ThorntonJ, WinkleDM, StanleyAWH, OlssonRA, DowneyJM. Protection against infarction afforded by preconditioning is mediated by Al adenosine receptors in rabbit heart. Circulation84:350–356, 1991.
31.
TsuchidaA, LiuY, LiuGS, CohenMV, DowneyJM. α1-Adrenergic agonists precondition rabbit ischemic myocardium independent of adenosine by direct activation of protein kinase C. Circ Res75:576–585, 1994.
32.
YaoZ, GrossGJ. Role of nitric oxide, muscarinic receptors, and the ATP-sensitive K+ channel in mediating the effects of acetylcholine to mimic preconditioning in dogs. Circ Res73:1193–1201, 1993.
33.
GrassGJ, ArchampachJA. Blockade of ATP-sensitive K+ channels prevents myocardial preconditioning in dogs. Circ Res70:223–233, 1992.
34.
GottliebRA, GruolDL, ZhuJY, EnglerRL. Preconditioning in rabbit cardiomyocytes: Role of pH, vacuolar proton ATPase, and apoptosis. J Clin Invest97:2391–2398, 1996.
35.
BolliR, ManchikalapudiS, TangXL, TakanoH, QiuY, ZhangQ, JadoonAK. The protective effect of late preconditioning against myocardial stunning in conscious rabbits is mediated by nitric oxide synthase: Evidence that nitric oxide acts both as a trigger and as a mediator of the late phase of ischemic preconditioning. Circ Res81:1094–1107, 1997.
VeghA, SzekeresL, ParrattJR. Protective effects of preconditioning of the ischemic myocardium involve cyclooxygenase products. Cardiovasc Res24:1020–1023, 1990.
38.
RouslinW, PullmannME. Protonic inhibition of the mitochondrial adenosine 5'-triphosphatase in ischemic cardiac muscle: Reversible binding of the ATPase inhibitor protein to the mitochondrial ATPase during ischemia. J Mol Cell Cardiol19:661–668, 1987.
39.
ElliottGT, MeiDE, GrossGJ. Monophosphoryl lipid A attenuates myocardial stunning in dogs: Role of ATP-sensitive potassium channels. J Cardiovasc Pharmacol32:49–56, 1998.
40.
MengX, BrownJM, AoLO, NordeenSK, FranklinW, HarkenAH, BanerjeeA.Endotoxin induces cardiac HSP70 and resistance to endotoxemic myocardial depression in rats. Am J Physiol271:C1316–C1324, 1996.
41.
HillJH, WardPA. The phlogistic role of C3 leukotactic fragments in myocardial infarcts of rats. J Exp Med133:885–900, 1971.
42.
JollySR, KaneWJ, HookBG, AbramsGD, KunkelSL, LucchesiBR. Reduction of myocardial infarct size by neutrophil depletion: Effect of duration of occlusion. Am Heart J112:682–690, 1986.
43.
GalianesM, LawsonCS, FerrariR, LimbGA, DeriasNW, HearseDJ. Early and late effects of leukipenic reperfusion on the recovery of cardiac contractile function: Studies in the transplanted and isolate blood-perfused rat heart. Circulation88:673–683, 1993.
44.
Barroso-ArandaJ, Schmid-SchonbeinGW, ZweifachBW, MathisonJC. Polymorphonuclear neutrophil contribution to induced tolerance to bacterial lipopolysaccharide. Circ Res69:1196–1206, 1991.
45.
YaoA, FosterPA, GrossGJ. Monophosphoryl lipid A protects against endotoxic shock via inhibiting neutrophil infiltration and preventing disseminated intravascular coagulation. Circ Shock43:107–114, 1994.
46.
GreggDE. Effect of coronary perfusion pressure are coronary flow on oxygen usage of the myocardium. Circ Res13:497–500, 1963.
47.
ArnoldG, KoscheF, MiessnerE, NietzertA, LochnerW.The importance of the perfusion pressure in the coronary arteries for the contractility and the oxygen consumption of the heart. Pfluegers Arch299:339–356, 1968.
48.
HenryPD, ShuchleibR, DavisJ, WeissES, SobelBE. Myocardial contracture and accumulation of mitochondrial calcium in ischemic rabbit heart. Am J Physiol233(6):H677–H684, 1977.
49.
ZhaoL, KirschCC, HagenSR, ElliottGT. Preservation of global cardiac function in the rabbit following protracted ischemia/reperfusion using monophosphoryl lipid A (MLA). J Mol Cell Cardiol28:197–208, 1996.
50.
ButcherEC. Leukocyte-endothelial cell recognition: Three (or more) steps to specificity and diversity. Cell67:1033–1036, 1991.
51.
PoberJS, CotranRS. The role of endothelial cells in inflammation. Transplantation50:537–544, 1990.
52.
FinnA, StrobelS, LevinM, KleinN.Endotoxin-induced neutrophil adherence to endothelium: Relationship to CD11b/Cd18 and L-selectin expression and matrix disruption. Ann N Y Acad Sci724:173–182, 1994.
